They have in their goals and milestones to announce partnership and biosynthesis inm the 3Q! If we dont hear a word by end of this Q, I might start thinking of an exit strategy. At some point they have to start generating revenue to satisfy TSX requirements and Eight Capital isn't going to like their money staying stagnant. They'll want return on investment. Inmed will have to put up or shut up at some point.
News 
Market Data 
Discover 
